Cargando…

Substance P Receptor Antagonism: A Potential Novel Treatment Option for Viral-Myocarditis

Viral-myocarditis is an important cause of heart failure for which no specific treatment is available. We previously showed the neuropeptide substance P (SP) is associated with the pathogenesis of murine myocarditis caused by encephalomyocarditis virus (EMCV). The current studies determined if pharm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robinson, Prema, Taffet, George E., Engineer, Nikita, Khumbatta, Mitra, Firozgary, Bahrom, Reynolds, Corey, Pham, Thuy, Bulsara, Tushar, Firozgary, Gohar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363507/ https://www.ncbi.nlm.nih.gov/pubmed/25821814 http://dx.doi.org/10.1155/2015/645153

Ejemplares similares

Somatostatin Negatively Regulates Parasite Burden and Granulomatous Responses in Cysticercosis
por: Khumbatta, Mitra, et al.
Publicado: (2014)

Corrigendum to “Somatostatin Negatively Regulates Parasite Burden and Granulomatous Responses in Cysticercosis”
por: Khumbatta, Mitra, et al.
Publicado: (2015)

Substance P Causes Seizures in Neurocysticercosis
por: Robinson, Prema, et al.
Publicado: (2012)

Substance P Antagonism Prevents Chemotherapy-Induced Cardiotoxicity
por: Legi, Ashiq, et al.
Publicado: (2021)

Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance
por: Robinson, Prema, et al.
Publicado: (2016)

Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis
por: Rodriguez, Emma, et al.
Publicado: (2021)

Erratum: Rodriguez et al. Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis. Cancers 2021, 13, 3871
por: Rodriguez, Emma, et al.
Publicado: (2021)

Microbial Antagonisms and Antibiotic Substances
por: Smith, Geo. H.
Publicado: (1945)

Microbial Antagonisms and Antibiotic Substances
por: Smith, Geo. H.
Publicado: (1947)

Substance P—Friend or Foe
por: Robinson, Prema, et al.
Publicado: (2022)

Genetic and Small-Molecule Modulation of Stat3 in a Mouse Model of Crohn’s Disease
por: Robinson, Prema, et al.
Publicado: (2022)

Neurokinin-1 Receptor Antagonists as a Potential Novel Therapeutic Option for Osteosarcoma Patients
por: Robinson, Prema, et al.
Publicado: (2023)

Cardio-Immunology of Myocarditis: Focus on Immune Mechanisms and Treatment Options
por: Maisch, Bernhard
Publicado: (2019)

Therapeutic options and challenges for substances of abuse
por: Gardner, Tracie J., et al.
Publicado: (2007)

Treatment options in myocarditis and inflammatory cardiomyopathy: Focus on i. v. immunoglobulins
por: Maisch, B., et al.
Publicado: (2018)

Therapeutic Potential of a Small-Molecule STAT3 Inhibitor in a Mouse Model of Colitis
por: Robinson, Prema, et al.
Publicado: (2023)

Acute viral myocarditis
por: Dennert, Robert, et al.
Publicado: (2008)

Toxic myocarditis presenting as an acute coronary syndrome
por: Kalekar, Tushar, et al.
Publicado: (2022)

Comparison of COVID-19 Vaccine-Associated Myocarditis and Viral Myocarditis Pathology
por: Hamedi, Kamron Reza, et al.
Publicado: (2023)

Orexin antagonism and substance-P: Effects and interactions on polycystic ovary syndrome in the wistar rats
por: Kouhetsani, Somayeh, et al.
Publicado: (2023)

Roles of inflammasomes in viral myocarditis
por: Xu, Jingyu, et al.
Publicado: (2023)

Substance P Signaling Contributes to Granuloma Formation in Taenia crassiceps Infection, a Murine Model of Cysticercosis
por: Garza, Armandina, et al.
Publicado: (2010)

Anhedonia and Substance Dependence: Clinical Correlates and Treatment Options
por: Hatzigiakoumis, Daniele Stavros, et al.
Publicado: (2011)

Statin-Induced Triad of Autoimmune Myocarditis, Myositis, and Transaminitis
por: Ajmal, Muhammad, et al.
Publicado: (2021)

Viral myocarditis vs lupus myocarditis, distinctive features in Cardiovascular Magnetic Resonance
por: Barillas, Maria A Espinoza
Publicado: (2016)

Necroptosis and Viral Myocarditis: Tumor Necrosis Factor α as a Novel Biomarker for the Diagnosis of Viral Myocarditis
por: Zhou, Jin, et al.
Publicado: (2022)

Comparison of Multisystem Inflammatory Syndrome in Children–Related Myocarditis, Classic Viral Myocarditis, and COVID‐19 Vaccine‐Related Myocarditis in Children
por: Patel, Trisha, et al.
Publicado: (2022)

Consideration on pathogen of viral fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

Viral Myocarditis—From Pathophysiology to Treatment
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2021)

A Case of Multifactorial Viral Myocarditis
por: Zaveri, Sahil, et al.
Publicado: (2021)

VIRAL MYOCARDITIS IN THE COVID-19 PANDEMIC
por: Banbury, Zachary, et al.
Publicado: (2021)

Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination Compared With Viral Myocarditis
por: Lai, Francisco Tsz Tsun, et al.
Publicado: (2022)

Damage to hepatic cellular membranes by chlorinated olefins with emphasis on synergism and antagonism.
por: Reynolds, E S, et al.
Publicado: (1977)

Noninvasive imaging in the diagnosis of acute viral myocarditis
por: Jeserich, Michael
Publicado: (2010)

Glucocorticoid and immunoglobulin to treat viral fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

The Role of Non-coding RNAs in Viral Myocarditis
por: Zhang, Cong, et al.
Publicado: (2020)

Severe T-System Remodeling in Pediatric Viral Myocarditis
por: Fiegle, Dominik J., et al.
Publicado: (2021)

Viral Myocarditis: Classification, Diagnosis, and Clinical Implications
por: Sozzi, Fabiola B., et al.
Publicado: (2022)

Selective D3 receptor antagonism modulates neural response during negative emotional processing in substance dependence
por: Vamvakopoulou, Ioanna A., et al.
Publicado: (2022)

Requirements within the Ebola Viral Glycoprotein for Tetherin Antagonism
por: Vande Burgt, Nathan H., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2uk19sap6g502h7ctdi1t7kkt9